A clinical trial update dated October 26, 2026 was recorded for the study titled "A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)," registered as NCT05767736. The trial's current status is listed as active, not recruiting. No phase was specified in the available record. This trial focuses on long-term safety evaluation in participants with multiple sclerosis and involves the drugs Vumerity and Tecfidera. No results or outcome data were included in this update. The status indicates the study is ongoing but is no longer enrolling new participants. No additional details regarding trial design, participant numbers, or endpoints were provided in this record. This update pertains to Vumerity and Tecfidera specifically and does not include new information about glatiramer. For readers seeking background on glatiramer, further context is available in the compound overview.
Trial Update: Long-Term Safety Study of Vumerity, Tecfidera Active
See the full glatiramer overview
Source: https://clinicaltrials.gov/study/NCT05767736